Osaka, Japan

Yasuyuki Nagasawa

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osaka University. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuyuki Nagasawa. Retrieved from https://idiyas.com/inventor/yasuyuki-nagasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuyuki Nagasawa: Innovator in IgA Nephropathy Detection

Introduction

Yasuyuki Nagasawa is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of IgA nephropathy. His innovative approach has the potential to improve patient outcomes through early detection and intervention.

Latest Patents

Nagasawa holds a patent for a method for detecting presumed IgA nephropathy and a method for screening IgA nephropathy patients. This process involves detecting bacteria present in a sample from the tonsil of a subject who may have a positive result in a urinary protein test or a urinary occult blood test. Additionally, it identifies patients for whom tonsillectomy may be effective by detecting specific bacteria, including Campylobacter bacteria.

Career Highlights

Nagasawa is affiliated with Osaka University, where he conducts research and develops innovative diagnostic methods. His work has garnered attention for its potential to enhance the understanding and management of IgA nephropathy.

Collaborations

He collaborates with notable colleagues, including Kenichiro Iio and Yoshitaka Isaka, to advance research in this critical area of healthcare.

Conclusion

Yasuyuki Nagasawa's contributions to the detection of IgA nephropathy exemplify the impact of innovative thinking in medical diagnostics. His work not only advances scientific knowledge but also holds promise for improving patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…